Contract 36E79724A0017
Mayne Pharma Commercial Llc · Department Of Veterans Affairs · May 28, 2024
Mayne Pharma Commercial Llc was awarded a federal contract by Department Of Veterans Affairs on May 28, 2024 for an undisclosed amount of work in pharmaceutical preparation manufacturing. This is a task or delivery order issued under parent IDIQ V797D50564. The contract has been modified 5 times since the base award It uses firm fixed-price contract pricing. The most recent modification was on December 16, 2025. If all options are exercised, the contract could reach $5.22 million.
Contract details
- PIID
- 36E79724A0017
- Parent IDIQ
- V797D50564
- Award type
- —
- Pricing
- Firm Fixed Price
- Competition
- Full And Open Competition
- NAICS
- 325412 · Pharmaceutical Preparation Manufacturing
- Product / service
- Drugs And Biologicals
- First action
- May 28, 2024
- Latest action
- December 16, 2025
Description
BPA CANCELLATION
Modification timeline
-
December 16, 2025Mod P00005$0
-
May 13, 2025Mod P00004EXERCISE OPTION YEAR 1$0
-
December 10, 2024Mod P000032025 PUBLIC LAW PRICING UPDATES$0
-
December 9, 2024Mod P00002PRODUCT DELETION$0
-
August 28, 2024Mod P00001PRODUCT ADDITIONS$0
-
May 28, 2024Base awardBPA FOR HALOBETASOL AND TAZAROTEN$0
Similar contracts
| Recipient | Agency | Date | Obligated |
|---|---|---|---|
| Petnet Solutions, Inc. | Department Of Veterans Affairs | April 1, 2026 | $387.4K |
| Eli Lilly And Company | Department Of Veterans Affairs | April 1, 2026 | $0 |
| Exelan Pharmaceuticals Inc | Department Of Veterans Affairs | April 1, 2026 | $0 |
| Cardinal Health 414, Llc | Department Of Veterans Affairs | April 1, 2026 | $122.9K |
| Guardian Pharmacy Of Indianapolis Nuclear, Llc | Department Of Veterans Affairs | April 1, 2026 | $0 |
| Jubilant Draximage Inc | Department Of Veterans Affairs | April 1, 2026 | $0 |
Top contractors in NAICS 325412
Lifetime obligated dollars across all federal contracts in this NAICS code.
| # | Contractor | Contracts | Obligated |
|---|---|---|---|
| 1 | Mckesson Corporation | 53,729 | $99.76B |
| 2 | Pfizer Inc | 4,613 | $28.68B |
| 3 | Merck Sharp & Dohme Llc | 391 | $21.58B |
| 4 | Modernatx, Inc. | 3 | $8.20B |
| 5 | Sanofi Vaccines Us Inc. | 5,248 | $7.76B |
| 6 | Glaxosmithkline, Llc | 1,418 | $7.22B |
| 7 | Merck Sharp & Dohme Corp. | 349 | $5.33B |
| 8 | Pfizer Inc. | 3,842 | $4.83B |
| 9 | Eli Lilly And Company | 18 | $4.67B |
| 10 | Amerisourcebergen Drug Corp | 497 | $3.23B |
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract 36E79724A0017?
Contract 36E79724A0017 is a federal contract awarded to Mayne Pharma Commercial Llc by Department Of Veterans Affairs on May 28, 2024 for an undisclosed amount of work classified under PHARMACEUTICAL PREPARATION MANUFACTURING. It has been modified 5 times since the base award.
Who won contract 36E79724A0017?
Mayne Pharma Commercial Llc won contract 36E79724A0017 from Department Of Veterans Affairs.
How much is contract 36E79724A0017 worth?
Contract 36E79724A0017 has obligated $0 to date but carries a potential ceiling of $5.22 million if fully funded and all options are exercised.